Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency

Blood

Volumn 111, Issue 10, 2008, Pages 4973-4978

  Zhang, Jing ^a   Tu, Yizheng ^a   Lu, Lan ^a   Lasky, Nina ^a   Broze Jr , George J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 5; CALCIUM ION; COLLAGEN; FATTY ACID BINDING PROTEIN; PHOSPHOLIPID; PROTEIN Z DEPENDENT PROTEASE INHIBITOR; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMA PROTEIN; PLASMA PROTEIN Z; SERINE PROTEINASE INHIBITOR; SERPINA10 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE DELETION; GENE DISRUPTION; LUNG EMBOLISM; MORTALITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; THROMBOSIS; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; MOUSE MUTANT;

ANIMALS; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; FACTOR V; FACTOR XIA; MICE; MICE, KNOCKOUT; PHENOTYPE; PULMONARY EMBOLISM; SERPINS; THROMBOSIS;

EID: 46749095636     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-12-126391     Document Type: Article

References (35)

1. Broze G Jr, Miletich J. Human protein Z. J Clin Invest. 1984;73:933-938.
2. Sejima H, Hayashi T, Deyashiki Y, Nishioka J, Suzuki K. Primary structure of vitamin K-dependent human protein Z. Biochem Biophys Res Commun. 1990;171:661-668.
3. Ichinose A, Takeya H, Espling E, Iwanaga S, Kisiel W, Davie E. Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. Biochem Biophys Res Commun. 1990;172:1139-1144.
4. Han X, Fiehler R, Broze G Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA. 1998;97:6734-6738.
5. Han X, Huang Z-F, Fiehler R, Broze G Jr. The protein Z-dependent protease inhibitor is a serpin. Biochemistry. 1999;38:11073-11078.
6. Miletich J, Broze G Jr. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood. 1987;69:1580-1586.
7. Al-Shanqeeti A, van Hycklama A, Berntorp E, Rosendaal FR, Broze GJ Jr. Protein Z and protein Z-dependent protease inhibitor: determinants of levels and risk of venous thrombosis. Thromb Haemost. 2006;93:411-413.
8. Vossen CY, Hasstedt SJ, Rosendaal FR, et al. Heritability of plasma concentrations of clotting factors and measures of a prothrombotic state in a protein C-deficient family. J Thromb Haemost. 2004;2:242-247.
9. Tabatabai A, Fiehler R, Broze G Jr. Protein Z circulates in plasma in a complex with protein Z- dependent protease inhibitor. Thromb Haemost. 2001;85:655-660.
10. Han X, Fiehler R, Broze G Jr. Characterization of protein Z-dependent protease inhibitor. Blood. 2000;96:3049-3055.
11. Rezaie AR, Sun M-F, Gailani D. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity. Biochemistry. 2006;45: 9427-9433.
12. Yin Z-F, Huang Z-F, Cui J, Lasky N, Ginsburg D, Broze GJ Jr. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci U S A. 2000;97: 6734-6738.
13. Zhang J, Broze GJ Jr. Mouse protein Z-dependent protease inhibitor cDNA. Thromb Haemost. 2001;85: 861-865.
14. Cui J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood. 2000;96:4222-4226.
15. DiMinno G, Silver MJ. Mouse antithrombotic assay: A simple method for the evaluation of antithromotic agents in vivo: potentiation of antithrombotic activity by ethyl alcohol. J Pharmacol Exp Ther. 1983;225:57-60.
16. Renne T, Nieswandt B, Gailani D. The intrinsic pathway of coagulation is essential for thrombus stability in mice. Blood Cells Mol Dis. 2006;36: 148-151.
17. Heeb MJ, Cabral KM, Ruan L. Down-regulation of factor IXa in the factor Xase complex by protein Z-dependent protease inhibitor. J Biol Chem. 2005;280:33819-33825.
18. Vasse M, Guegan-Massardier E, Borg J-Y, Woimant F, Soria C. High frequency of protein Z deficiency in patients with ischemic stroke. Lancet. 2001;357:933-934.
19. Heeb M, Paganini-Hill A, Griffin J, Fisher M. Low protein Z levels and risk of ischemic stroke; differences by diabetic status and gender. Blood Cells Mol Dis. 2002;29:139-144.
20. Fedi S, Sofi F, Brogi D, et al. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost. 2003;90:1173-1178.
21. Sofi F, Cesari F, Vigiani S, et al. Protein Z plasma levels in different phases of activity of coronary atherosclerosis. J Thromb Haemost. 2005;3: 2254-2258.
22. Morange PE, Juhan-Vague I, and the PRIME study group. Protein Z plasma levels are not associated with the risk of coronary heart disease: The PRIME study. J Thromb Haemost. 2004;2: 2050-2051.
23. McQuillan A, Eikelboom J, Hankey G, et al. Protein Z in ischemic stroke and its etiologic subtypes. Stroke. 2003;34:2415-2419.
24. Santacroce R, Sarno M, Cappucci F, et al. Protein Z low levels and risk of occurrence of deep venous thrombosis. J Thromb Haemost. 2006;4: 2417-2422.
25. Martenilli I, Razzari E, Bucciarelli P, Mannucci PM. Low levels of protein Z and the risk of venous thromboembolism. J Thromb Haemost. 2005;3: 2817-2819.
26. Gris J-C, Quere I, Dechaud H, et al. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood. 2002;99: 2606-2608.
27. Van de Water N, Tan T, Ashton F, et al. Mutations within the protein Z- dependent protease inhibitor gene are associated with venous thromboembolic disease: a new form of thrombophilia. Brit J Haemat. 2004;127:190-194.
28. Corral J, Gonzalez-Conejero R, Soria JM, et al. A nonsense polymorphism in the protein Z- dependent protease inhibitor increases the risk for venous thrombosis. Blood. 2006;108:177-183.
29. Razzari C, Marinelli I, Bucciarelli P, Viscardi Y, Biguzzi E. Polymorphisms of the protein Z- dependent protease inhibitor (ZPI) gene and the risk of venous thromboembolism. Thromb Haemost. 2006;95:909-910.
30. Folsom AR, Cushman M, Rasmussen-Torvik LJ, Heckbert SR, Tsai MY. Prospective study of polymorphisms of the protein Z-dependent protease inhibitor and risk of venous thromboembolism. Thromb Haemost. 2007;97:493-494.
31. Refaai MA, Ahn C, Lu L, Wu K, Broze GJ Jr. Protein Z and ZPI levels and cardiovascular events. J Thromb Haemost. 2006;4:1628-1629.
32. Kemkes-Matthes B, Matzdorff A, Matthes K. Protein Z influences the prothrombotic phenotype of factor V Leiden in humans. Thromb Res. 2002; 106:183-185.
33. Jalert LR, Rosen ED, Moons L, et al. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest. 1998;102:1481-1488.
34. Ishiguro K, KojimaT, Kadomatsu K, et al. Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest. 2000;106:873-878.
35. Huang ZF, Higuchi D, Lasky N, Broze GJ Jr. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 1997;90:944-951.